A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients

Julien Pothlichet, Timothy B. Niewold, Damien Vitour, Brigitte Solhonne, Mary K. Crow, Mustapha Si-Tahar

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Dysregulation of the antiviral immune response may contribute to autoimmune diseases. Here, we hypothesized that altered expression or function of MAVS, a key molecule downstream of the viral sensors RIG-I and MDA-5, may impair antiviral cell signalling and thereby influence the risk for systemic lupus erythematosus (SLE), the prototype autoimmune disease. We used molecular techniques to screen non-synonymous single nucleotide polymorphisms (SNPs) in the MAVS gene for functional significance in human cell lines and identified one critical loss-of-function variant (C79F, rs11905552). This SNP substantially reduced expression of type I interferon (IFN) and other proinflammatory mediators and was found almost exclusively in the African-American population. Importantly, in African-American SLE patients, the C79F allele was associated with low type I IFN production and absence of anti-RNA-binding protein autoantibodies. These serologic associations were not related to a distinct, functionally neutral, MAVS SNP Q198K. Hence, this is the first demonstration that an uncommon genetic variant in the MAVS gene has a functional impact upon the anti-viral IFN pathway in vivo in humans and is associated with a novel sub-phenotype in SLE. This study demonstrates the utility of functional data in selecting rare variants for genetic association studies, allowing for fewer comparisons requiring statistical correction and for alternate lines of evidence implicating the particular variant in disease.

Original languageEnglish (US)
Pages (from-to)142-152
Number of pages11
JournalEMBO Molecular Medicine
Volume3
Issue number3
DOIs
StatePublished - Mar 2011
Externally publishedYes

Fingerprint

Systemic Lupus Erythematosus
Antiviral Agents
Single Nucleotide Polymorphism
Interferon Type I
African Americans
Autoimmune Diseases
RNA-Binding Proteins
Genetic Association Studies
Autoantibodies
Interferons
Genes
Alleles
Phenotype
Cell Line
Population

Keywords

  • Cell signalling
  • Immune response
  • Lupus
  • Polymorphisms
  • Virus

ASJC Scopus subject areas

  • Molecular Medicine

Cite this

A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients. / Pothlichet, Julien; Niewold, Timothy B.; Vitour, Damien; Solhonne, Brigitte; Crow, Mary K.; Si-Tahar, Mustapha.

In: EMBO Molecular Medicine, Vol. 3, No. 3, 03.2011, p. 142-152.

Research output: Contribution to journalArticle

Pothlichet, Julien ; Niewold, Timothy B. ; Vitour, Damien ; Solhonne, Brigitte ; Crow, Mary K. ; Si-Tahar, Mustapha. / A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients. In: EMBO Molecular Medicine. 2011 ; Vol. 3, No. 3. pp. 142-152.
@article{2058df2196f94b609db01c575a4fd9d4,
title = "A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients",
abstract = "Dysregulation of the antiviral immune response may contribute to autoimmune diseases. Here, we hypothesized that altered expression or function of MAVS, a key molecule downstream of the viral sensors RIG-I and MDA-5, may impair antiviral cell signalling and thereby influence the risk for systemic lupus erythematosus (SLE), the prototype autoimmune disease. We used molecular techniques to screen non-synonymous single nucleotide polymorphisms (SNPs) in the MAVS gene for functional significance in human cell lines and identified one critical loss-of-function variant (C79F, rs11905552). This SNP substantially reduced expression of type I interferon (IFN) and other proinflammatory mediators and was found almost exclusively in the African-American population. Importantly, in African-American SLE patients, the C79F allele was associated with low type I IFN production and absence of anti-RNA-binding protein autoantibodies. These serologic associations were not related to a distinct, functionally neutral, MAVS SNP Q198K. Hence, this is the first demonstration that an uncommon genetic variant in the MAVS gene has a functional impact upon the anti-viral IFN pathway in vivo in humans and is associated with a novel sub-phenotype in SLE. This study demonstrates the utility of functional data in selecting rare variants for genetic association studies, allowing for fewer comparisons requiring statistical correction and for alternate lines of evidence implicating the particular variant in disease.",
keywords = "Cell signalling, Immune response, Lupus, Polymorphisms, Virus",
author = "Julien Pothlichet and Niewold, {Timothy B.} and Damien Vitour and Brigitte Solhonne and Crow, {Mary K.} and Mustapha Si-Tahar",
year = "2011",
month = "3",
doi = "10.1002/emmm.201000120",
language = "English (US)",
volume = "3",
pages = "142--152",
journal = "EMBO Molecular Medicine",
issn = "1757-4676",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients

AU - Pothlichet, Julien

AU - Niewold, Timothy B.

AU - Vitour, Damien

AU - Solhonne, Brigitte

AU - Crow, Mary K.

AU - Si-Tahar, Mustapha

PY - 2011/3

Y1 - 2011/3

N2 - Dysregulation of the antiviral immune response may contribute to autoimmune diseases. Here, we hypothesized that altered expression or function of MAVS, a key molecule downstream of the viral sensors RIG-I and MDA-5, may impair antiviral cell signalling and thereby influence the risk for systemic lupus erythematosus (SLE), the prototype autoimmune disease. We used molecular techniques to screen non-synonymous single nucleotide polymorphisms (SNPs) in the MAVS gene for functional significance in human cell lines and identified one critical loss-of-function variant (C79F, rs11905552). This SNP substantially reduced expression of type I interferon (IFN) and other proinflammatory mediators and was found almost exclusively in the African-American population. Importantly, in African-American SLE patients, the C79F allele was associated with low type I IFN production and absence of anti-RNA-binding protein autoantibodies. These serologic associations were not related to a distinct, functionally neutral, MAVS SNP Q198K. Hence, this is the first demonstration that an uncommon genetic variant in the MAVS gene has a functional impact upon the anti-viral IFN pathway in vivo in humans and is associated with a novel sub-phenotype in SLE. This study demonstrates the utility of functional data in selecting rare variants for genetic association studies, allowing for fewer comparisons requiring statistical correction and for alternate lines of evidence implicating the particular variant in disease.

AB - Dysregulation of the antiviral immune response may contribute to autoimmune diseases. Here, we hypothesized that altered expression or function of MAVS, a key molecule downstream of the viral sensors RIG-I and MDA-5, may impair antiviral cell signalling and thereby influence the risk for systemic lupus erythematosus (SLE), the prototype autoimmune disease. We used molecular techniques to screen non-synonymous single nucleotide polymorphisms (SNPs) in the MAVS gene for functional significance in human cell lines and identified one critical loss-of-function variant (C79F, rs11905552). This SNP substantially reduced expression of type I interferon (IFN) and other proinflammatory mediators and was found almost exclusively in the African-American population. Importantly, in African-American SLE patients, the C79F allele was associated with low type I IFN production and absence of anti-RNA-binding protein autoantibodies. These serologic associations were not related to a distinct, functionally neutral, MAVS SNP Q198K. Hence, this is the first demonstration that an uncommon genetic variant in the MAVS gene has a functional impact upon the anti-viral IFN pathway in vivo in humans and is associated with a novel sub-phenotype in SLE. This study demonstrates the utility of functional data in selecting rare variants for genetic association studies, allowing for fewer comparisons requiring statistical correction and for alternate lines of evidence implicating the particular variant in disease.

KW - Cell signalling

KW - Immune response

KW - Lupus

KW - Polymorphisms

KW - Virus

UR - http://www.scopus.com/inward/record.url?scp=79952094197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952094197&partnerID=8YFLogxK

U2 - 10.1002/emmm.201000120

DO - 10.1002/emmm.201000120

M3 - Article

VL - 3

SP - 142

EP - 152

JO - EMBO Molecular Medicine

JF - EMBO Molecular Medicine

SN - 1757-4676

IS - 3

ER -